Linnaeus Therapeutics
Haddonfield
About Linnaeus Therapeutics
Linnaeus Therapeutics is a development stage biotech company engaged in the identification and development of small molecule agents that modulate cellular differentiation for the treatment of cancer and disorders of pigmentation.Linnaeus is a Penn Center for Innovation UPstart company that was founded in 2016 and is based upon discoveries from the Ridky lab at the University of Pennsylvania.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $58.6M
- Last round: Series Unknown (Feb 2026)
- Website: linnaeustx.com
- Phone: 856-433-1300
Industries & Categories
Biotechnology, Health Care, Medical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/linnaeus-therapeutics-74384 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.